These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 38254219)

  • 1. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.
    MacLean MR; Walker OL; Arun RP; Fernando W; Marcato P
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
    Manni W; Min W
    MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells, colorectal cancer and cancer stem cell markers correlations.
    Cherciu I; Bărbălan A; Pirici D; Mărgăritescu C; Săftoiu A
    Curr Health Sci J; 2014; 40(3):153-61. PubMed ID: 25729599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
    Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
    Harrop R; O'Neill E; Stern PL
    Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer Stem Cells and Targeted Agents.
    Zhao H; Han R; Wang Z; Xian J; Bai X
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.